Emergence of non-motor fluctuations with reference to motor fluctuations in Parkinson's disease

Aryun Kim; Han-Joon Kim; Chae Won Shin; Ahro Kim; Yoon Kim; Mihee Jang; Yu Jin Jung; Woong-Woo Lee; Hyeyoung Park; Beomseok Jeon

doi:10.1016/j.parkreldis.2018.04.020

Emergence of non-motor fluctuations with reference to motor fluctuations in Parkinson's disease

Parkinsonism Relat Disord. 2018 Sep:54:79-83. doi: 10.1016/j.parkreldis.2018.04.020. Epub 2018 Apr 19.

Authors

Aryun Kim¹, Han-Joon Kim¹, Chae Won Shin², Ahro Kim³, Yoon Kim¹, Mihee Jang¹, Yu Jin Jung⁴, Woong-Woo Lee⁵, Hyeyoung Park⁶, Beomseok Jeon⁷

Affiliations

¹ Department of Neurology, Movement Disorder Center, Seoul National University Hospital, Parkinson Study Group, Seoul National University College of Medicine, Seoul, South Korea.
² Department of Neurology, Kyung Hee University Medical Center, Seoul, South Korea.
³ Department of Neurology, Catholic University of Korea, Seoul, South Korea.
⁴ Department of Neurology, Daejeon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Daejeon, South Korea.
⁵ Department of Neurology, Nowon Eulji Medical Center, Eulji University, Seoul, South Korea.
⁶ Department of Neurology, Hallym Hospital, Incheon, South Korea.
⁷ Department of Neurology, Movement Disorder Center, Seoul National University Hospital, Parkinson Study Group, Seoul National University College of Medicine, Seoul, South Korea. Electronic address: brain@snu.ac.kr.

PMID: 29724602
DOI: 10.1016/j.parkreldis.2018.04.020

Abstract

Introduction: Non-motor fluctuations (NMF) and motor fluctuations (MF) are frequent in patients with Parkinson's disease (PD) with long-term medical treatment. We aimed to examine the timing of the emergence of NMF with reference to MF in a prospective cohort of patients with PD without symptom fluctuations.

Methods: A total of 334 patients with PD who had neither MF nor NMF were recruited. The exclusion criteria included a Mini-Mental State Examination score of less than 26 points at baseline and an alternative diagnosis or significant comorbidity during follow-up. The "SNUH-Fluctuation Questionnaire" consisting of 29 items (9 on MF and 20 on NMF) was administered on a semi-annually basis for 3 years.

Results: Three hundred seven out of 334 patients were analyzed for symptom fluctuations with the Kaplan-Meier survival analysis. MF were observed in more patients and developed earlier than NMF (cumulative survival of 0.572 for MF and 0.619 for NMF at 36 months of follow-up). In 212 patients who finished the follow-up for 36 months, MF and NMF developed simultaneously in 58 (27.4%), MF developed first in 45 (21.2%), and NMF developed first in only 3 (1.4%). The remaining 106 patients (50.0%) did not develop either MF or NMF.

Conclusion: NMF developed simultaneously with or later than MF. From these data, we hypothesize that NMF develop in the disease state where the pathology in the brain has been severe enough to develop MF. Hence, pharmacologic management should consider targeting both dopaminergic and non-dopaminergic systems to treat NMF.

Keywords: Follow-up studies; Incidence; Levodopa; Parkinson disease; Prospective studies; Surveys and questionnaires.

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Aged
Autonomic Nervous System / physiopathology*
Behavioral Symptoms / etiology
Behavioral Symptoms / physiopathology*
Cognitive Dysfunction / etiology
Cognitive Dysfunction / physiopathology*
Disease Progression*
Female
Follow-Up Studies
Humans
Incidence
Kaplan-Meier Estimate
Male
Middle Aged
Parkinson Disease / complications
Parkinson Disease / physiopathology*
Prospective Studies